Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bacher

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|September 16, 1998
Antifungal activity of the pradimicin derivative BMS 181184 in the treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbitsC E Gonzalez, A H Groll, N Giri, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokineticsA H Groll, C E Gonzalez, N Giri, et al.
Bone Marrow Transplantation|January 31, 2006
Conversion of the severe to the moderate disease phenotype with donor leukocyte microchimerism in canine leukocyte adhesion deficiencyY-C Gu, T R Bauer, R A Sokolic, et al.
Cytokine|August 14, 2001
Recombinant human macrophage colony-stimulating factor augments pulmonary host defences against Aspergillus fumigatusC E Gonzalez, C A Lyman, S Lee, et al.
Epilepsia|June 24, 1998
Ictal scalp EEG in unilateral mesial temporal lobe epilepsyE Pataraia, S Lurger, W Serles, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbitsV Petraitis, R Petraitiene, A H Groll, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2001
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasisV Petraitis, R Petraitiene, A H Groll, et al.
Transfusion|March 1, 1993
Plasma exchange does not improve survival in a canine model of human septic shockC Natanson, W D Hoffman, L A Koev, et al.
The Journal of Infectious Diseases|July 1, 1992
Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosisT J Walsh, J W Lee, G P Melcher, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1991
Effects of pituitary-testicular axis suppression in utero and during the early neonatal period with a long-acting luteinizing hormone-releasing hormone analog on genital development, somatic growth, and bone density in male cynomolgus monkeys in the first 6 months of lifeL Liu, A M Cristiano, J L Southers, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|September 16, 1998
Antifungal activity of the pradimicin derivative BMS 181184 in the treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbitsC E Gonzalez, A H Groll, N Giri, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokineticsA H Groll, C E Gonzalez, N Giri, et al.
Bone Marrow Transplantation|January 31, 2006
Conversion of the severe to the moderate disease phenotype with donor leukocyte microchimerism in canine leukocyte adhesion deficiencyY-C Gu, T R Bauer, R A Sokolic, et al.
Cytokine|August 14, 2001
Recombinant human macrophage colony-stimulating factor augments pulmonary host defences against Aspergillus fumigatusC E Gonzalez, C A Lyman, S Lee, et al.
Epilepsia|June 24, 1998
Ictal scalp EEG in unilateral mesial temporal lobe epilepsyE Pataraia, S Lurger, W Serles, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbitsV Petraitis, R Petraitiene, A H Groll, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2001
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasisV Petraitis, R Petraitiene, A H Groll, et al.
Transfusion|March 1, 1993
Plasma exchange does not improve survival in a canine model of human septic shockC Natanson, W D Hoffman, L A Koev, et al.
The Journal of Infectious Diseases|July 1, 1992
Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosisT J Walsh, J W Lee, G P Melcher, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1991
Effects of pituitary-testicular axis suppression in utero and during the early neonatal period with a long-acting luteinizing hormone-releasing hormone analog on genital development, somatic growth, and bone density in male cynomolgus monkeys in the first 6 months of lifeL Liu, A M Cristiano, J L Southers, et al.
Pageof 8